Stephanie Sproule
About
In The Last Decade
Stephanie Sproule
10 papers receiving 2.7k citations
Hit Papers
Peers
Comparison fields: 5 of 77
- Physiology 2.5k
- Pulmonary and Respiratory Medicine 1.8k
- Immunology 627
- Surgery 597
- Immunology and Allergy 588
Countries citing papers authored by Stephanie Sproule
This map shows the geographic impact of Stephanie Sproule's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephanie Sproule with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephanie Sproule more than expected).
Fields of papers citing papers by Stephanie Sproule
This network shows the impact of papers produced by Stephanie Sproule. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephanie Sproule. The network helps show where Stephanie Sproule may publish in the future.
Co-authorship network of co-authors of Stephanie Sproule
This figure shows the co-authorship network connecting the top 25 collaborators of Stephanie Sproule. A scholar is included among the top collaborators of Stephanie Sproule based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephanie Sproule. Stephanie Sproule is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 7 | |
| 2 | 13 | |
| 3 | 1 | |
| 4 | 4 | |
| 5 | 19 | |
| 6 | 3 | |
| 7 | Oral Glucocorticoid–Sparing Effect of Benralizumab in Severe Asthma breakdown → | 716 |
| 8 | Benralizumab, an anti-interleukin-5 receptor α monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial breakdown → | 984 |
| 9 | Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial breakdown → | 976 |
| 10 | 2 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.